{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:53:59Z","timestamp":1761177239720,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolism"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.diabet.2020.10.005","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T09:10:37Z","timestamp":1604567437000},"page":"101207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fasting serum copeptin and asymptomatic peripheral artery disease: No association in patients with type 1 diabetes mellitus"],"prefix":"10.1016","volume":"47","author":[{"given":"L\u00eda","family":"Nattero-Ch\u00e1vez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8354-7284","authenticated-orcid":false,"given":"Mar\u00eda \u00c1ngeles","family":"Mart\u00ednez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Fern\u00e1ndez-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Redondo L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Dorado Avenda\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor F.","family":"Escobar-Morreale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6002-4237","authenticated-orcid":false,"given":"Manuel","family":"Luque-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2020.10.005_bib0005","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1210\/jc.2007-0232","article-title":"Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects","volume":"92","author":"Szinnai","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2020.10.005_bib0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/CS20080140","article-title":"Gender and renal function influence plasma levels of copeptin in healthy individuals","volume":"116","author":"Bhandari","year":"2009","journal-title":"Clin Sci"},{"key":"10.1016\/j.diabet.2020.10.005_bib0015","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1007\/s00125-016-4011-7","article-title":"Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: the British Regional Heart Study","volume":"59","author":"Wannamethee","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2020.10.005_bib0020","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.2337\/dc16-1003","article-title":"Plasma copeptin, kidney outcomes, ischemic heart disease, and all-cause mortality in people with long-standing type 1 diabetes","volume":"39","author":"Velho","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2020.10.005_bib0025","doi-asserted-by":"crossref","first-page":"e3088","DOI":"10.1002\/dmrr.3088","article-title":"The peripheral atherosclerotic profile in patients with type 1 diabetes warrants a thorough vascular assessment of asymptomatic patients","volume":"35","author":"Nattero-Ch\u00e1vez","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabet.2020.10.005_bib0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1358863x06070516","article-title":"Guidelines for noninvasive vascular laboratory testing: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology","volume":"11","author":"Gerhard-Herman","year":"2006","journal-title":"Vasc Med"},{"key":"10.1016\/j.diabet.2020.10.005_bib0035","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.2337\/dc19-1062","article-title":"Plasma copeptin and risk of lower-extremity amputation in type 1 and type 2 Diabetes","volume":"42","author":"Potier","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2020.10.005_bib0040","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00432.2009","article-title":"Vasopressin is a major vasoconstrictor involved in hindlimb vascular responses to stimulation of adenosine A(1) receptors in the nucleus of the solitary tract","volume":"297","author":"McClure","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.diabet.2020.10.005_bib0045","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/1354750X.2019.1631886","article-title":"Copeptin, B-type natriuretic peptide and cystatin C are associated with incident symptomatic PAD","volume":"24","author":"Fatemi","year":"2019","journal-title":"Biomarkers"},{"key":"10.1016\/j.diabet.2020.10.005_bib0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000181521","article-title":"Abnormal arginine-vasopressin responses to metoclopramide and insulin-induced hypoglycemia in type I diabetes mellitus","volume":"33","author":"Coiro","year":"1990","journal-title":"Horm Res"},{"key":"10.1016\/j.diabet.2020.10.005_bib0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2337\/diab.28.5.503","article-title":"Plasma vasopressin in uncontrolled diabetes mellitus","volume":"28","author":"Zerbe","year":"1979","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2020.10.005_bib0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5551\/jat.44891","article-title":"Inflammatory mediators across the spectrum of ankle-brachial index","volume":"26","author":"Ozkaramanli Gur","year":"2019","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.diabet.2020.10.005_bib0065","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/1479164114544464","article-title":"Plasma copeptin as marker of cardiovascular disease in asymptomatic type 2 diabetes patients","volume":"11","author":"Bar-Shalom","year":"2014","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.diabet.2020.10.005_bib0070","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00125-019-4835-z","article-title":"Lower limb events in individuals with type 2 diabetes: evidence for an increased risk associated with diuretic use","volume":"62","author":"Potier","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2020.10.005_bib0075","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Diabetes & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363620301580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363620301580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:57:00Z","timestamp":1761130620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363620301580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1262363620301580"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2020.10.005","relation":{},"ISSN":["1262-3636"],"issn-type":[{"type":"print","value":"1262-3636"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fasting serum copeptin and asymptomatic peripheral artery disease: No association in patients with type 1 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101207"}}